COMMUNIQUÉS West-GlobeNewswire

Homology Medicines Reports Third Quarter 2018 Financial Results
13/11/2018
On Track to Begin and Report Initial Clinical Data from PKU Gene Therapy Trial and to Start IND-Enabling Studies in PKU Gene Editing and MLD Gene Therapy Programs Next Year BEDFORD, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE [...]
Teligent, Inc. Announces Third Quarter 2018 Results
13/11/2018
BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter [...]
Teligent, Inc. Announces $120 Million Financing Commitment From Ares
13/11/2018
BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that the Company secured a financing commitment from funds managed by Ares Management, L.P. (“ [...]
Resonant Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update
13/11/2018
GOLETA, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless [...]
electroCore, Inc. Announces Third Quarter Financial Results
13/11/2018
BASKING RIDGE, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today reported financial results for the three months and nine [...]
Merit Medical Closes Cianna Medical, Inc. Deal
13/11/2018
SOUTH JORDAN, Utah, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Evoke Pharma Reports Third Quarter 2018 Results
13/11/2018
April 1, 2019 PDUFA date for Gimoti™ NDA Cash runway extended through June 2019 SOLANA BEACH, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on [...]
ImmuCell Announces Financial Results for Third Quarter of 2018
13/11/2018
PORTLAND, Maine, Nov. 13, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Marrone Bio Innovations, Inc. Reports Third Quarter 2018 Financial Results
13/11/2018
Year-Over-Year Revenues Increase 29% to Third Quarter Record of $5.4 Million; Gross Margins Expand to Record 48.3%; Operating Expenses Decrease by 19% to $6.8 Million DAVIS, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- [...]
Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Sol-Gel Technologies Reports Third Quarter 2018 Financial Results
13/11/2018
NESS ZIONA, Israel, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
aTyr Pharma Announces Third Quarter 2018 Operating Results and Provides Corporate Update
13/11/2018
- Initiation of Proof-of-Concept Study in Patients with Pulmonary Sarcoidosis Planned for Fourth Quarter of 2018 - - Conference Call Today at 5:00 p.m. ET / 2:00 p.m. PT – SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- [...]
Guardant Health To Report Third Quarter Financial Results on November 19, 2018
13/11/2018
REDWOOD CITY, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter of 2018 after market close on Monday, November 19, 2018. [...]
OpGen Reports third quarter 2018 Financial Results and Provides Business Update
13/11/2018
Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., Nov. 13, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today reported financial and operating results for the three and nine months ended [...]
iCAD Reports Third Quarter 2018 Financial Results
13/11/2018
Company announces board and leadership changes Conference call today at 4:30 p.m. ET NASHUA, N.H., Nov. 13, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology company providing innovative [...]
Imprimis Pharmaceuticals Announces Third Quarter 2018 Results
13/11/2018
SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported results for the third quarter 2018. Third Quarter 2018 and Other Recent Notable Highlights: Revenues increased 66 [...]
Capricor Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
To Host Conference Call and Webcast Today at 4:30 p.m. ET LOS ANGELES, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first- [...]
CareDx Announces Proposed Public Offering of Common Stock
13/11/2018
BRISBANE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
IntelGenx Closes Private Placement Financing
13/11/2018
SAINT LAURENT, Quebec, Nov. 13, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces the closing of Tilray, Inc.’s strategic investment in IntelGenx by [...]

Pages